Ethic Inc.

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1780570 NEW YORK, NY

Position in TEVA

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$590,502

+$24,759 QoQ

Shares Held

19,605

+8.2% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

13 quarters on record

Voting authority Sole 96.41418005610814.ToString("F0")% Shared 0.ToString("F0")% None 3.5858199438918645.ToString("F0")%

Healthcare · as of Mar 31, 2026

Ethic Inc. holds $17,529,957 across 9 Drug Manufacturers - Specialty & Generic names. TEVA ranks #8 (3.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TAK	Takeda Pharmaceutical Co Ltd	334,836	$6,201,162
2	ZTS	Zoetis Inc.	38,751	$4,580,755
3	RDY	Dr Reddys Laboratories Ltd	120,027	$1,662,373
4	ELAN	Elanco Animal Health Inc	64,231	$1,537,047
5	VTRS	Viatris Inc	90,477	$1,222,344
6	HLN	Haleon plc	105,141	$1,052,461
7	UTHR	UNITED THERAPEUTICS Corp	1,078	$639,232
8	TEVA	Teva Pharmaceutical Industries Ltd This page	19,605	$590,502

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$590,502	19,605	+8.2%	Shares	Sole	2026-04-27
2025-12-31	$565,743	18,127	+1.8%	Shares	Sole	2026-02-03
2025-09-30	$359,600	17,802	-3.7%	Shares	Sole	2025-10-17
2025-06-30	$309,892	18,490	-7.0%	Shares	Sole	2025-07-30
2025-03-31	$305,693	19,889	-64.0%	Shares	Sole	2025-05-13
2024-12-31	$1,219,318	55,323	+45.4%	Shares	Sole	2025-02-14
2024-09-30	$685,769	38,056	-14.2%	Shares	Sole	2024-11-13
2024-06-30	$721,110	44,376	+11.0%	Shares	Sole	2024-08-13
2024-03-31	$564,103	39,979	+256.0%	Shares	Sole	2024-05-13
2023-12-31	$117,251	11,231	-1.5%	Shares	Sole	2024-02-14
2023-09-30	$116,351	11,407	-21.0%	Shares	Sole	2023-11-14
2023-03-31	$127,847	14,446	+7.9%	Shares	Sole	2023-05-12
2022-09-30	$108,073	13,392	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.